RekrutujeFaza I
An Early-Stage Study in Multiple Clinics of how Afimkibart May Affect the Body’s Processing of Medicines that Rely on Cytochrome P450 Enzymes in Patients with Ulcerative Colitis
Miasta: Bydgoszcz, Lublin, Nowy Targ, Pabianice i 5 innych miastWiek: 18-64 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza III
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Miasta: Białystok, Bydgoszcz, Dębica, Lublin i 6 innych miastWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza II
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Miasta: Katowice, Kraków, Oświęcim, Pabianice i 2 inne miastaWiek: od 18 latSponsor: Ipsen Innovation
RekrutujeFaza III
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Miasta: Białystok, Bydgoszcz, Chojnice, Karczew i 16 innych miastWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza II
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Miasta: Kraków, Lublin, Pabianice, Poznań i 8 innych miastWiek: od 18 latSponsor: Boehringer Ingelheim International GmbH